Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1996;3(4):173–183. doi: 10.1155/MBD.1996.173

The Hypolipidemic Activity of Boronated Nucleosides in Male Mice and Rats

Bruce S Burnham 1, Anup Sood 2, Jeno Tomasz 2, W J Powell 2, Bernard F Spielvogel 2, S Y Chen 1, Iris H Hall 1,✉
PMCID: PMC2365024  PMID: 18475753

Abstract

The boronated nucleosides with varying bases and sugar moieties were shown to be potent hypolipidemic agents in rodents. The 3′– aminocynaoborane dideoxythymidine derivative caused reductions in serum cholesterol and triglyceride levels, tissue lipids, VLDL and LDL cholesterol levels while elevating HDL cholesterol levels in rodents. The agents suppressed rat hepatic acetyl CoA synthetase, HMG-CoA reductase, acyl-CoA cholesterol acyl transferase, phosphatidylate phosphohydrolase and lipoprotein lipase activities while elevating cholesterol-7α-hydroxylase activity from 25 to 100 μM.

Full Text

The Full Text of this article is available as a PDF (602.2 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES